Logo image of PROT.OL

PROTECTOR FORSIKRING ASA (PROT.OL) Stock Fundamental Analysis

OSL:PROT - Euronext Oslo - NO0010209331 - Common Stock - Currency: NOK

364.5  +12 (+3.4%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PROT. PROT was compared to 34 industry peers in the Insurance industry. Both the profitability and the financial health of PROT get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, PROT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year PROT was profitable.
In the past year PROT had a positive cash flow from operations.
Each year in the past 5 years PROT has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PROT reported negative operating cash flow in multiple years.
PROT.OL Yearly Net Income VS EBIT VS OCF VS FCFPROT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of PROT (6.24%) is better than 100.00% of its industry peers.
PROT has a Return On Equity of 28.29%. This is amongst the best in the industry. PROT outperforms 100.00% of its industry peers.
PROT has a better Return On Invested Capital (7.34%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PROT is significantly above the industry average of 2.22%.
Industry RankSector Rank
ROA 6.24%
ROE 28.29%
ROIC 7.34%
ROA(3y)7.22%
ROA(5y)6.78%
ROE(3y)32.76%
ROE(5y)33%
ROIC(3y)7.88%
ROIC(5y)6.75%
PROT.OL Yearly ROA, ROE, ROICPROT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

With a decent Profit Margin value of 12.62%, PROT is doing good in the industry, outperforming 76.47% of the companies in the same industry.
In the last couple of years the Profit Margin of PROT has declined.
With an excellent Operating Margin value of 19.13%, PROT belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
In the last couple of years the Operating Margin of PROT has declined.
Industry RankSector Rank
OM 19.13%
PM (TTM) 12.62%
GM N/A
OM growth 3Y-8.32%
OM growth 5YN/A
PM growth 3Y-15.26%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PROT.OL Yearly Profit, Operating, Gross MarginsPROT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PROT is destroying value.
Compared to 1 year ago, PROT has about the same amount of shares outstanding.
Compared to 5 years ago, PROT has more shares outstanding
Compared to 1 year ago, PROT has an improved debt to assets ratio.
PROT.OL Yearly Shares OutstandingPROT.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PROT.OL Yearly Total Debt VS Total AssetsPROT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 1.98 indicates that PROT is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 1.98, PROT belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
PROT has a debt to FCF ratio of 1.55. This is a very positive value and a sign of high solvency as it would only need 1.55 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.55, PROT is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that PROT is not too dependend on debt financing.
PROT has a better Debt to Equity ratio (0.35) than 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.55
Altman-Z 1.98
ROIC/WACC0.88
WACC8.36%
PROT.OL Yearly LT Debt VS Equity VS FCFPROT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 0.18 indicates that PROT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.18, PROT is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
A Quick Ratio of 0.18 indicates that PROT may have some problems paying its short term obligations.
The Quick ratio of PROT (0.18) is better than 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
PROT.OL Yearly Current Assets VS Current LiabilitesPROT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

PROT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.04%.
Measured over the past 5 years, PROT shows a small growth in Earnings Per Share. The EPS has been growing by 7.66% on average per year.
PROT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.60%.
The Revenue has been growing by 22.85% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2.04%
EPS 3Y7.66%
EPS 5YN/A
EPS Q2Q%-63.58%
Revenue 1Y (TTM)18.6%
Revenue growth 3Y27.1%
Revenue growth 5Y22.85%
Sales Q2Q%12.27%

3.2 Future

Based on estimates for the next years, PROT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.18% on average per year.
The Revenue is expected to grow by 8.81% on average over the next years. This is quite good.
EPS Next Y13.15%
EPS Next 2Y14.67%
EPS Next 3Y12.18%
EPS Next 5YN/A
Revenue Next Year10.48%
Revenue Next 2Y8.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PROT.OL Yearly Revenue VS EstimatesPROT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B
PROT.OL Yearly EPS VS EstimatesPROT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.50, the valuation of PROT can be described as rather expensive.
Based on the Price/Earnings ratio, PROT is valued a bit more expensive than the industry average as 70.59% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 28.79, PROT is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.45 indicates a rather expensive valuation of PROT.
Based on the Price/Forward Earnings ratio, PROT is valued expensively inside the industry as 85.29% of the companies are valued cheaper.
PROT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.5
Fwd PE 17.45
PROT.OL Price Earnings VS Forward Price EarningsPROT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, PROT is valued a bit more expensive than the industry average as 61.76% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 24.61
EV/EBITDA N/A
PROT.OL Per share dataPROT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PROT has a very decent profitability rating, which may justify a higher PE ratio.
PROT's earnings are expected to grow with 12.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.48
PEG (5Y)N/A
EPS Next 2Y14.67%
EPS Next 3Y12.18%

0

5. Dividend

5.1 Amount

No dividends for PROT!.
Industry RankSector Rank
Dividend Yield N/A

PROTECTOR FORSIKRING ASA

OSL:PROT (4/25/2025, 7:00:00 PM)

364.5

+12 (+3.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)01-30 2025-01-30/amc
Earnings (Next)04-24 2025-04-24
Inst Owners36%
Inst Owner ChangeN/A
Ins Owners1.74%
Ins Owner ChangeN/A
Market Cap30.07B
Analysts84.44
Price Target379.95 (4.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend9
Dividend Growth(5Y)N/A
DP48.23%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.72%
Min Revenue beat(2)1.85%
Max Revenue beat(2)7.59%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.68%
PT rev (3m)11.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.5%
EPS NY rev (3m)2.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.5
Fwd PE 17.45
P/S 2.47
P/FCF 24.61
P/OCF 23.24
P/B 5.53
P/tB 5.65
EV/EBITDA N/A
EPS(TTM)18.69
EY5.13%
EPS(NY)20.89
Fwd EY5.73%
FCF(TTM)14.81
FCFY4.06%
OCF(TTM)15.68
OCFY4.3%
SpS147.78
BVpS65.93
TBVpS64.52
PEG (NY)1.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.24%
ROE 28.29%
ROCE 9.64%
ROIC 7.34%
ROICexc 7.48%
ROICexgc 8.14%
OM 19.13%
PM (TTM) 12.62%
GM N/A
FCFM 10.02%
ROA(3y)7.22%
ROA(5y)6.78%
ROE(3y)32.76%
ROE(5y)33%
ROIC(3y)7.88%
ROIC(5y)6.75%
ROICexc(3y)8%
ROICexc(5y)6.86%
ROICexgc(3y)8.73%
ROICexgc(5y)8.12%
ROCE(3y)10.35%
ROCE(5y)8.87%
ROICexcg growth 3Y-2.94%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.7%
ROICexc growth 5YN/A
OM growth 3Y-8.32%
OM growth 5YN/A
PM growth 3Y-15.26%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.55
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 79.42%
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 1.98
F-Score5
WACC8.36%
ROIC/WACC0.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.04%
EPS 3Y7.66%
EPS 5YN/A
EPS Q2Q%-63.58%
EPS Next Y13.15%
EPS Next 2Y14.67%
EPS Next 3Y12.18%
EPS Next 5YN/A
Revenue 1Y (TTM)18.6%
Revenue growth 3Y27.1%
Revenue growth 5Y22.85%
Sales Q2Q%12.27%
Revenue Next Year10.48%
Revenue Next 2Y8.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.76%
EBIT growth 3Y16.52%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2877.27%
FCF growth 3Y10.04%
FCF growth 5Y-2.19%
OCF growth 1Y4571.48%
OCF growth 3Y10.09%
OCF growth 5Y-1.74%